閉経後膣萎縮（PVA）：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
2.3 Upcoming Related Reports 9
3 Market Outlook 10
3.1 Global Markets 10
3.1.1 Forecast 10
3.1.2 Drivers and Barriers – Global Issues 13
4 Current and Future Players 15
4.1 Overview 15
4.2 Trends in Corporate Strategy 17
4.3 Company Profiles 18
4.3.1 Pfizer 18
4.3.2 Shionogi 21
4.3.3 Novo Nordisk 23
4.3.4 Actavis 25
4.3.5 Bayer AG 26
5 Appendix 28
5.1 Bibliography 28
5.2 Abbreviations 29
5.3 Methodology 31
5.4 Forecasting Methodology 31
5.4.1 Diagnosed postmenopausal atrophy patients 31
5.4.2 Percent Drug-Treated Patients 32
5.4.3 General Pricing Assumptions 32
5.5 Physicians and Specialists Included in This Study 33
5.6 About the Authors 35
5.6.1 Author 35
5.6.2 Director of Oncology, Hematology and Gender Health 35
5.6.3 Global Head of Healthcare 36
5.7 About GlobalData 37
5.8 Disclaimer 37